185 related articles for article (PubMed ID: 16679074)
41. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair.
Jeon H; Meng W; Takagi J; Eck MJ; Springer TA; Blacklow SC
Nat Struct Biol; 2001 Jun; 8(6):499-504. PubMed ID: 11373616
[TBL] [Abstract][Full Text] [Related]
42. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
[TBL] [Abstract][Full Text] [Related]
43. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.
Chong B; Hegde M; Fawkner M; Simonet S; Cassinelli H; Coker M; Kanis J; Seidel J; Tau C; Tüysüz B; Yüksel B; Love D;
J Bone Miner Res; 2003 Dec; 18(12):2095-104. PubMed ID: 14672344
[TBL] [Abstract][Full Text] [Related]
44. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.
Mozas P; Castillo S; Tejedor D; Reyes G; Alonso R; Franco M; Saenz P; Fuentes F; Almagro F; Mata P; Pocoví M
Hum Mutat; 2004 Aug; 24(2):187. PubMed ID: 15241806
[TBL] [Abstract][Full Text] [Related]
45. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density.
Urano T; Shiraki M; Ezura Y; Fujita M; Sekine E; Hoshino S; Hosoi T; Orimo H; Emi M; Ouchi Y; Inoue S
J Bone Miner Metab; 2004; 22(4):341-5. PubMed ID: 15221492
[TBL] [Abstract][Full Text] [Related]
46. Screening for new mutations in the LDL receptor gene in seven French familial hypercholesterolemia families by the single strand conformation polymorphism method.
Loux N; Saint-Jore B; Collod G; Dairou F; Benlian P; Truffert J; Dastugue B; Douste-Blazy P; de Gennes JL; Junien C
Hum Mutat; 1992; 1(4):325-32. PubMed ID: 1301940
[TBL] [Abstract][Full Text] [Related]
47. Lrp5 and bone formation : A serotonin-dependent pathway.
Yadav VK; Ducy P
Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
[TBL] [Abstract][Full Text] [Related]
48. [Genetic background of osteoporosis].
Takács I; Lakatos P
Orv Hetil; 2003 Jul; 144(30):1467-72. PubMed ID: 14569676
[TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family.
Brown SD; Twells RC; Hey PJ; Cox RD; Levy ER; Soderman AR; Metzker ML; Caskey CT; Todd JA; Hess JF
Biochem Biophys Res Commun; 1998 Jul; 248(3):879-88. PubMed ID: 9704021
[TBL] [Abstract][Full Text] [Related]
50. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
51. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
52. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
Gong Y; Slee RB; Fukai N; Rawadi G; Roman-Roman S; Reginato AM; Wang H; Cundy T; Glorieux FH; Lev D; Zacharin M; Oexle K; Marcelino J; Suwairi W; Heeger S; Sabatakos G; Apte S; Adkins WN; Allgrove J; Arslan-Kirchner M; Batch JA; Beighton P; Black GC; Boles RG; Boon LM; Borrone C; Brunner HG; Carle GF; Dallapiccola B; De Paepe A; Floege B; Halfhide ML; Hall B; Hennekam RC; Hirose T; Jans A; Jüppner H; Kim CA; Keppler-Noreuil K; Kohlschuetter A; LaCombe D; Lambert M; Lemyre E; Letteboer T; Peltonen L; Ramesar RS; Romanengo M; Somer H; Steichen-Gersdorf E; Steinmann B; Sullivan B; Superti-Furga A; Swoboda W; van den Boogaard MJ; Van Hul W; Vikkula M; Votruba M; Zabel B; Garcia T; Baron R; Olsen BR; Warman ML;
Cell; 2001 Nov; 107(4):513-23. PubMed ID: 11719191
[TBL] [Abstract][Full Text] [Related]
53. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.
Ferrari SL; Deutsch S; Antonarakis SE
Curr Opin Lipidol; 2005 Apr; 16(2):207-14. PubMed ID: 15767861
[TBL] [Abstract][Full Text] [Related]
54. Low-density lipoprotein receptor-related protein 5 polymorphisms are associated with bone mineral density in Greek postmenopausal women: an interaction with calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Katsalira A; Hammond N; Deloukas P; Lyritis GP
J Am Diet Assoc; 2010 Jul; 110(7):1078-83. PubMed ID: 20630166
[TBL] [Abstract][Full Text] [Related]
55. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
Koay MA; Brown MA
Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771
[TBL] [Abstract][Full Text] [Related]
56. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome.
Gastier JM; Berg MA; Vesterhus P; Reiter EO; Francke U
Hum Mutat; 2000 Oct; 16(4):323-33. PubMed ID: 11013443
[TBL] [Abstract][Full Text] [Related]
57. [Wnt-beta-catenin signaling in bone metabolism].
Urano T
Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
[TBL] [Abstract][Full Text] [Related]
58. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men.
Saarinen A; Välimäki VV; Välimäki MJ; Löyttyniemi E; Auro K; Uusen P; Kuris M; Lehesjoki AE; Mäkitie O
Bone; 2007 Apr; 40(4):1006-12. PubMed ID: 17223614
[TBL] [Abstract][Full Text] [Related]
59. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP.
Nikopoulos K; Venselaar H; Collin RW; Riveiro-Alvarez R; Boonstra FN; Hooymans JM; Mukhopadhyay A; Shears D; van Bers M; de Wijs IJ; van Essen AJ; Sijmons RH; Tilanus MA; van Nouhuys CE; Ayuso C; Hoefsloot LH; Cremers FP
Hum Mutat; 2010 Jun; 31(6):656-66. PubMed ID: 20340138
[TBL] [Abstract][Full Text] [Related]
60. Parameters of LRP5 from a structural and molecular perspective.
Johnson ML; Summerfield DT
Crit Rev Eukaryot Gene Expr; 2005; 15(3):229-42. PubMed ID: 16390319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
